GB0119863D0 - DNA-PK inhibitors - Google Patents

DNA-PK inhibitors

Info

Publication number
GB0119863D0
GB0119863D0 GBGB0119863.9A GB0119863A GB0119863D0 GB 0119863 D0 GB0119863 D0 GB 0119863D0 GB 0119863 A GB0119863 A GB 0119863A GB 0119863 D0 GB0119863 D0 GB 0119863D0
Authority
GB
United Kingdom
Prior art keywords
sub
sup
dna
optionally substituted
heterocyclyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0119863.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Priority to GBGB0119863.9A priority Critical patent/GB0119863D0/en
Publication of GB0119863D0 publication Critical patent/GB0119863D0/en
Priority to US10/486,811 priority patent/US7105518B2/en
Priority to EP02751427A priority patent/EP1416936B1/en
Priority to ES02751427T priority patent/ES2243750T3/es
Priority to AT02751427T priority patent/ATE296633T1/de
Priority to PCT/GB2002/003740 priority patent/WO2003015790A1/en
Priority to JP2003520749A priority patent/JP4299666B2/ja
Priority to DE60204468T priority patent/DE60204468T2/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
GBGB0119863.9A 2001-08-14 2001-08-14 DNA-PK inhibitors Ceased GB0119863D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB0119863.9A GB0119863D0 (en) 2001-08-14 2001-08-14 DNA-PK inhibitors
US10/486,811 US7105518B2 (en) 2001-08-14 2002-08-14 Thiopyrane-4-ones as DNA protein kinase inhibitors
EP02751427A EP1416936B1 (en) 2001-08-14 2002-08-14 Thiopyrane-4-ones as dna protein kinase inhibitors
ES02751427T ES2243750T3 (es) 2001-08-14 2002-08-14 Tiopirano-4-onas como inhibidores de la dna proteinquinasa.
AT02751427T ATE296633T1 (de) 2001-08-14 2002-08-14 Thiopyran-4-one als inhibitoren der dna protein kinase
PCT/GB2002/003740 WO2003015790A1 (en) 2001-08-14 2002-08-14 Thiopyrane-4-ones as dna protein kinase inhibitors
JP2003520749A JP4299666B2 (ja) 2001-08-14 2002-08-14 Ｄｎａプロテインキナーゼ阻害剤としてのチオピラン−４−オン類
DE60204468T DE60204468T2 (de) 2001-08-14 2002-08-14 Thiopyran-4-one als inhibitoren der dna protein kinase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0119863.9A GB0119863D0 (en) 2001-08-14 2001-08-14 DNA-PK inhibitors

Publications (1)

Publication Number Publication Date
GB0119863D0 true GB0119863D0 (en) 2001-10-10

Family

ID=9920418

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0119863.9A Ceased GB0119863D0 (en) 2001-08-14 2001-08-14 DNA-PK inhibitors

Country Status (8)

Country Link
US (1) US7105518B2 (https=)
EP (1) EP1416936B1 (https=)
JP (1) JP4299666B2 (https=)
AT (1) ATE296633T1 (https=)
DE (1) DE60204468T2 (https=)
ES (1) ES2243750T3 (https=)
GB (1) GB0119863D0 (https=)
WO (1) WO2003015790A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0119865D0 (en) * 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0209891D0 (en) * 2002-04-30 2002-06-05 Glaxo Group Ltd Novel compounds
EP1654257B1 (en) * 2003-08-13 2010-03-17 Kudos Pharmaceuticals Limited Aminopyrones and their use as atm inhibitors
TW200616986A (en) * 2004-09-20 2006-06-01 Kudos Pharm Ltd DNA-pk inhibitors
JP2008529995A (ja) * 2005-02-09 2008-08-07 クドス ファーマシューティカルズ リミテッド Ａｔｍ阻害剤
AR054438A1 (es) * 2005-04-15 2007-06-27 Kudos Pharm Ltd Inhibidores de adn -pk
EP1895997A2 (en) * 2005-05-26 2008-03-12 Kudos Pharmaceuticals Ltd Use of dna-pk inhibition to sensitise atm deficient cancers to dna-damaging cancer therapies
UY31232A1 (es) * 2007-07-19 2009-03-02 Compuestos derivados de dibenzotifenilamino-cromen-4-onas activas sustituidas y sus isomeros y aplicaciones
BR112021022536A2 (pt) * 2019-05-10 2021-12-28 Shanghai Haiyan Pharmaceutical Tech Co Ltd Derivado de fenilpropenilpiridina substituída e método de preparação do mesmo e uso médico do mesmo

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1303724A (https=) 1969-05-14 1973-01-17
JPH0753725B2 (ja) 1987-10-08 1995-06-07 富山化学工業株式会社 ４ｈ―１―ベンゾピラン―４―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤
US5284856A (en) 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
WO1990006921A1 (en) 1988-12-21 1990-06-28 The Upjohn Company Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
US5703075A (en) 1988-12-21 1997-12-30 Pharmacia & Upjohn Company Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
JPH03215423A (ja) 1990-01-18 1991-09-20 Kyowa Hakko Kogyo Co Ltd 血管拡張剤
JPH05509302A (ja) 1990-06-20 1993-12-22 ジ・アップジョン・カンパニー 抗アテローム性動脈硬化性および抗血栓性１―ベンゾピラン―４―オン類および２―アミノ―１，３―ベンゾオキサジン―４―オン類
EP0489877B1 (en) 1990-06-29 1995-09-20 The Upjohn Company Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones
US5302613A (en) 1990-06-29 1994-04-12 The Upjohn Company Antiatheroscleroic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones
US5252735A (en) 1990-06-29 1993-10-12 The Upjohn Company Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones
JP3215423B2 (ja) 1992-01-18 2001-10-09 ザ・ユニバーシティ・オブ・ニューキャッスル・アポン・タイン 導電性ポリマーの製法
EP0610519B1 (en) 1992-09-02 1999-12-01 Kyowa Hakko Kogyo Co., Ltd. Anti-hiv drug
WO1994023714A1 (fr) 1993-04-09 1994-10-27 Toyama Chemical Co., Ltd. Immunomodulateur, inhibiteur de l'adherence cellulaire, et agent permettant de traiter et de prevenir des maladies auto-immunes
US5378725A (en) 1993-07-19 1995-01-03 The Arizona Board Of Regents Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
US5468773A (en) 1993-08-25 1995-11-21 Eli Lilly And Company Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs
US5441947A (en) 1993-08-25 1995-08-15 Eli Lilly And Company Methods of inhibiting vascular restenosis
US5504103A (en) 1993-08-25 1996-04-02 Eli Lilly And Company Inhibition of phosphatidylinositol 3-kinase with 17 β-hydroxywortmannin and analogs thereof
CA2133815A1 (en) 1993-10-12 1995-04-13 Jeffrey Alan Dodge Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof
US6632789B1 (en) 1994-04-29 2003-10-14 The United States Of America As Represented By The Secretary Of The Navy Methods for modulating T cell responses by manipulating intracellular signal transduction
US5480906A (en) 1994-07-01 1996-01-02 Eli Lilly And Company Stereochemical Wortmannin derivatives
GB9521987D0 (en) 1995-10-26 1996-01-03 Ludwig Inst Cancer Res Phosphoinositide 3-kinase modulators
US5733920A (en) 1995-10-31 1998-03-31 Mitotix, Inc. Inhibitors of cyclin dependent kinases
IL121306A0 (en) 1995-11-16 1998-01-04 Icos Corp Cell cycle checkpoint pik-related kinase materials and methods
GB2302021A (en) 1996-10-16 1997-01-08 Lilly Co Eli Inhibiting bone loss or resorption
AU7953598A (en) 1997-06-06 1998-12-21 Mayo Foundation For Medical Education And Research Screening for phosphatidylinositol related-kinase inhibitors
WO1998056391A1 (en) 1997-06-13 1998-12-17 President And Fellows Of Harvard College Methods for treating human cancers
FR2776291B1 (fr) 1998-03-18 2000-06-16 Pf Medicament Nouveaux derives bis-benzamides, leur procede de fabrication, les compositions pharmaceutiques les contenant et leur utilisation comme medicament
US6387640B1 (en) 1999-02-10 2002-05-14 St. Jude Children's Research Hospital ATM kinase modulation for screening and therapies
US6348311B1 (en) 1999-02-10 2002-02-19 St. Jude Childre's Research Hospital ATM kinase modulation for screening and therapies
EP1857443B1 (en) 2000-01-24 2012-03-28 AstraZeneca AB Therapeutic morpholino-substituted compounds
WO2002020500A2 (en) 2000-09-01 2002-03-14 Icos Corporation Materials and methods to potentiate cancer treatment
DE60203260T2 (de) 2001-01-16 2006-02-02 Glaxo Group Ltd., Greenford Pharmazeutische kombination, die ein 4-chinazolinamin und paclitaxel, carboplatin oder vinorelbin enthält, zur behandlung von krebs
GB0119865D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
US6894055B2 (en) 2001-10-24 2005-05-17 Iconix Pharmaceuticals Inc. Thieno-2′,3′ -5,6pyrimido[3,4-A]-1,2,4-triazole derivatives as modulators of phoshoinositide 3-kinase
AU2002349912A1 (en) 2001-10-24 2003-05-06 Iconix Pharmaceuticals, Inc. Modulators of phosphoinositide 3-kinase
EP2174939A1 (en) 2002-02-25 2010-04-14 Kudos Pharmaceuticals Limited Pyranones useful as ATM inhibitors
US7049313B2 (en) 2002-02-25 2006-05-23 Kudos Pharmaceuticals Ltd. ATM inhibitors
DE60335359D1 (de) 2002-04-30 2011-01-27 Kudos Pharm Ltd Phthalazinonderivate

Also Published As

Publication number Publication date
DE60204468D1 (de) 2005-07-07
JP4299666B2 (ja) 2009-07-22
ES2243750T3 (es) 2005-12-01
ATE296633T1 (de) 2005-06-15
US7105518B2 (en) 2006-09-12
US20050107367A1 (en) 2005-05-19
EP1416936A1 (en) 2004-05-12
EP1416936B1 (en) 2005-06-01
WO2003015790A1 (en) 2003-02-27
JP2005502656A (ja) 2005-01-27
DE60204468T2 (de) 2006-04-27

Similar Documents

Publication Publication Date Title
GB2393653B (en) DNA-PK inhibitors
YU84603A (sh) Novi inhibitori tirozin kinaze
CO5700824A2 (es) Nuevos compuestos heterociclicos utiles para el tratamiento de desordenes inflamatorios y alergicos: proceso para su preparacion y composiciones farmaceuticas que los contienen
MXPA04009497A (es) Piridinoilpiperidinas como antagonistas de 5-ht1f.
NO20020305D0 (no) Nye bisyklonukleosidanaloger
ATE442139T1 (de) 3-oxo-1,3-dihydro-indazol-2-carbonsäureamid derivate als phospholipase inhibitoren
TW200505874A (en) New compounds with therapeutic effect
DE602004016174D1 (de) Substituierte indazolyl(indolyl)maleimid-derivate als kinase inhibitoren
DE69332792T2 (de) 4,1-Benzoxazepinderivate als Squalen-Synthetase Inhibitoren und ihre Verwendung zur Behandlung von Hypercholesterämie und als Fungizide
GB2420781B (en) Aminopyrones and their use as ATM inhibitors
ATE243034T1 (de) Intimale verdickungsinhibitoren
TW200638938A (en) ATM inhibitors
DE60014394D1 (de) Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
GB0119863D0 (en) DNA-PK inhibitors
EA014959B3 (ru) Ингибиторы глицинового переносчика-1
PH12022551282A1 (en) Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
ZA200500436B (en) 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
ATE397609T1 (de) Corticotropinfreisetzungsfaktor antagonisten
ATE229538T1 (de) 22r-hydroxycholesta-8,14-diene derivate zur hemmung der meiose
ES2183500T3 (es) Nuevos compuestos y composiciones farmaceuticas que los contienen.
TW200612912A (en) Benzyloxy derivatives as maob inhibitors
ATE449773T1 (de) Homomorpholinoxazolidinone als antibakterielle mittel

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)